Role of RPL39 in Metaplastic Breast Cancer
Bhuvanesh Dave; Daniel D. Gonzalez; Zhi-Bin Liu; Xiaoxian Li; Helen Wong; Sergio Granados; Nadeer E. Ezzedine; Douglas H. Sieglaff; Joe E. Ensor; Kathy D. Miller; Milan Radovich; Agda KarinaEtrovic; Steven S. Gross; Olivier Elemento; Gordon B. Mills; Michael Z. Gilcrease; Jenny C. Chang
Author Information: Houston Methodist Cancer Center, Houston, TX (BD, DDG, ZBL, HW, SG, DHS, JEE, JCC); Division of Basic Science Research, Department of Systems Biology (NEE, AKE, GBM), and Division of Pathology/Lab Medicine, Department of Pathology (MZG), The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Breast Surgery, Shanghai Cancer Center and Cancer Institute of Fudan University, Shanghai, China (ZBL); Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA (XL); Department of Physiology and Biophysics, Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY (OE); Joan and Sanford I. Weill Medical School of Cornell University, New York, NY (SSG); Department of Medicine, Indiana University Medical School, Indianapolis, IN (KDM); Departments of Surgery and Medical and Molecular Genetics, IU Center for Computational Biology and Bioinformatics, Indianapolis, IN (MR).
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.